PHIROS: An integrated microfluidic platform for multi-day high-resolution imaging of organotypic slices

The authors present PHIROS, a microfluidic platform that enables long-term, high-resolution imaging and controlled perturbations of organotypic brain slices, thereby facilitating detailed mechanistic studies of cell interactions and tumor behavior within a physiologically relevant tissue context.

The Gist

Imagine trying to study how a city functions by looking at a single, flat map. You can see the streets and buildings, but you miss the traffic, the people interacting, and how the city changes over time. That's essentially what scientists have been doing with brain tissue for decades. They've tried to grow brain cells in flat dishes (2D), but these cells lose their complex "city-like" structure. Alternatively, they've tried to study whole animals, but that's like trying to watch a single conversation in a crowded stadium—it's hard to see the details, and it raises ethical concerns.

Enter PHIROS, a new invention that acts like a high-tech, transparent time machine for brain slices.

Here is the simple breakdown of what this paper is about, using some everyday analogies:

1. The Problem: The "Glass Ceiling" of Brain Research

For years, scientists have used "organotypic slices"—thin slices of real brain tissue that keep their natural structure and cell types. Think of these slices as a living, breathing cross-section of a city.

• The Issue: To keep these slices alive, they usually have to sit on a mesh with air above them (like a sandwich on a plate). This is great for keeping them alive, but terrible for looking at them. You can't put a high-powered microscope lens right on top of them without smushing them, and you can't keep them submerged in liquid (which they need for long-term viewing) because they would suffocate without oxygen.
• The Result: Scientists could only take quick "snapshots" or look at the tissue at the very end of an experiment. They couldn't watch the "movie" of what was happening inside the cells over days.

2. The Solution: PHIROS (The "Smart Aquarium")

The researchers built a microfluidic platform called PHIROS. Think of it as a custom-built, transparent aquarium designed specifically for a slice of brain tissue.

• The Design: It's a small chip made of clear plastic. The brain slice sits on a special membrane (like a breathable floor).
• The Magic Trick: The system pumps oxygen-rich liquid (nutrient soup) through the chip in a gentle, rhythmic pulse.
  • Analogy: Imagine a gentle tide coming in and out. This keeps the tissue submerged (so you can see it clearly with a microscope) but ensures it never runs out of oxygen, just like fish in a well-aerated tank.
• The Benefit: Because the tissue stays submerged and alive, scientists can now watch the same slice for days or even weeks with incredible clarity, seeing individual cells and even tiny parts inside them.

3. What They Discovered (The "Movies" They Filmed)

Using this new "aquarium," the team filmed two major stories:

Story A: The Brain's "Cellular Internet" (Calcium Signals)

They watched astrocytes (support cells in the brain) talk to each other.

• The Analogy: Imagine a crowd of people holding flashlights. When one person flashes, the light ripples through the crowd.
• The Discovery: They saw these "light flashes" (calcium signals) traveling through the brain tissue naturally. They even turned off the "internet" (by blocking the connections between cells) and watched the ripples stop. This proved the system works for studying how brain cells communicate in real-time.

Story B: The Brain Tumor Invasion (The "Tumor vs. City" Battle)

They introduced Medulloblastoma (a type of childhood brain tumor) cells into the healthy brain slices to see how they invade.

• The Analogy: Imagine a group of invaders trying to sneak into a fortified city.
• The Discovery:
  • Movement: The tumor cells didn't just swim randomly; they formed "convoys" and moved in specific directions, guided by the city's streets (the brain structure).
  • The "Bridge" (Microtubes): They saw the tumor cells building tiny, thread-like bridges to connect with healthy cells.
  • The "Package Delivery" (Mitochondria Transfer): The most exciting part? They watched the tumor cells stealing power plants (mitochondria) from the healthy brain cells through these bridges. It's like a thief sneaking into a house and stealing the generator to keep their own lights on. This helps the tumor survive and resist treatment.
  • The "Flag" (B7-H3): They also tracked a specific marker on the tumor cells (B7-H3) that acts like a flag. They found this flag was always at the very front of the invading cells, guiding them like a compass.

Why This Matters

Before PHIROS, studying these processes was like trying to understand a movie by looking at a single, blurry frame every few days. PHIROS allows scientists to watch the entire movie in high definition.

• For Cancer: It helps us understand exactly how brain tumors hide, move, and steal resources from healthy tissue. This could lead to better drugs that stop the "bridges" or the "stealing."
• For Medicine: It offers a way to test personalized treatments on a patient's own tissue slice without needing to experiment on a whole animal.

In a nutshell: PHIROS is a revolutionary tool that lets scientists peek inside the brain's living city, watch the cells interact in real-time, and understand the secrets of disease without destroying the neighborhood.

Technical Summary

1. Problem Statement

Replicating the complex cytoarchitecture and cell heterogeneity of the brain in vitro remains a significant challenge. While conventional models like 2D co-cultures, spheroids, and organoids offer insights, they fail to reproduce the native tissue environment, limiting the study of complex processes like neural network activity and tumor-host interactions.

• Limitations of Current Slice Models: Organotypic tissue slices preserve native complexity but are typically cultured at an air-liquid interface (ALI). This method restricts continuous optical access, confining imaging to short time windows or endpoint analyses.
• Limitations of In Vivo Models: Orthotopic tumor models offer physiological relevance but suffer from restricted imaging capabilities, require large numbers of cells, long preparation times, and raise ethical concerns, particularly for pediatric studies.
• The Gap: There is a lack of a system that combines the physiological relevance of organotypic slices with the ability to perform continuous, long-term, high-resolution (subcellular) imaging and controlled temporal perturbations (e.g., drug delivery) without compromising tissue viability.

2. Methodology: The PHIROS Platform

The authors developed PHIROS (Platform for High-Resolution imaging of Organotypic Slices), a microfluidic device designed to overcome the limitations of current slice culturing methods.

• Platform Architecture:
  • Materials: Constructed primarily from polymethylmethacrylate (PMMA) and a hydrophilic 0.4-µm-pore-diameter polytetrafluoroethylene (PTFE) membrane.
  • Components:
    1. Slice Holder: A PMMA base with a microfluidic channel for perfusion.
    2. Membrane: A PTFE membrane bonded to the holder, allowing gas exchange while supporting the tissue.
    3. Support & Sealing: A PMMA support part and an adhesive foil to seal the assembly.
  • Workflow:
    1. Static Phase: Slices are cultured on the chip (placed on a standard insert) at the ALI for 14–18 days to allow tissue recovery and reorganization (e.g., Purkinje cell layer reorganization).
    2. Perfusion Phase: The chip is sealed and transferred to a microscope stage. A closed-loop perfusion system is activated.
• Perfusion System:
  • Uses a custom-made gas exchanger to oxygenate the medium (~30 mg/L dissolved oxygen) before it enters the chip.
  • Pulsatile Flow Protocol: To minimize disruption of endogenous gradients while ensuring oxygen supply, the system uses hourly cycles of partial medium exchange followed by 1-hour no-flow intervals. This mimics static culture conditions while preventing hypoxia.
• Imaging Capabilities: Compatible with spinning-disk confocal microscopy, enabling continuous imaging from low magnification (4X/10X) to subcellular resolution (60X) over multiple days.

3. Key Contributions

• Novel Microfluidic Design: A dual-mode system supporting both static ALI culturing for tissue maturation and sealed perfusion for long-term imaging.
• Preservation of Viability: Demonstrated that pulsatile perfusion with oxygenated medium maintains tissue health and prevents hypoxia, a common failure point in submerged slice imaging.
• Versatile Application: Validated the platform for neuroscience (astrocyte calcium dynamics) and cancer research (medulloblastoma invasion, tumor-stroma interactions).
• High-Resolution Longitudinal Tracking: Enabled the tracking of subcellular events (mitochondrial transfer, actin remodeling) and cell-cell interactions over 3+ days without mechanical disturbance.

4. Key Results

A. Tissue Viability and Architecture

• Reorganization: Cerebellar slices cultured on PHIROS successfully reorganized, forming continuous Purkinje cell layers flanked by organized granular and molecular layers, comparable to in vivo metrics and standard ALI cultures.
• Viability: Over 48 hours of perfusion, apoptotic markers (cleaved caspase-3/7) remained low.
• Hypoxia Control: Immunostaining for HIF-1α showed that pulsatile perfusion maintained oxygen levels comparable to ALI controls, whereas static submerged slices showed a >16-fold increase in hypoxia markers.

B. Functional Imaging: Astrocytic Calcium Dynamics

• Spontaneous Activity: The platform allowed multi-day monitoring of spontaneous Ca²⁺ fluctuations in astrocytes (labeled with GCaMP6f).
• Subtype Differentiation: Distinct dynamics were observed between Bergmann glia (smaller, shorter events) and velate astrocytes (larger, longer events with higher connectivity).
• Pharmacological Perturbation: Application of the gap-junction inhibitor carbenoxolone (CBX) successfully disrupted network communication, reducing the size and duration of Ca²⁺ events, demonstrating the platform's ability to perform acute drug testing.

C. Medulloblastoma (MB) Invasion and TME Interactions

• Invasion Patterns: MB spheroids (ONS-76 cells) engrafted onto cerebellar slices exhibited heterogeneous motility. Unlike radial migration on dissociated cells, invasion on slices was spatially restricted and directional, mimicking in vivo behavior.
• Cell-Cell Interactions:
  • Tumor-Astrocyte: Tumor cells showed avoidance of high-density astrocyte regions but formed long-lasting contacts (12+ hours) in specific clusters, suggesting collective invasion.
  • B7-H3 Localization: The immune-checkpoint marker B7-H3 was found to accumulate persistently at the leading edge (lamellipodia) of invading tumor cells, suggesting a role in TME navigation beyond its immunomodulatory function.
• Organelle Trafficking: The platform captured mitochondrial transfer across actin-rich microtubes connecting tumor cells and tumor-microenvironment (TME) cells.
  • Mitochondria moved with a mean speed of 0.012 µm/s.
  • Tumor-TME microtubes were longer and thicker than tumor-tumor microtubes.
• Drug Response: Treatment with cytochalasin D (actin inhibitor) caused distinct morphological changes in slice-cultured cells (elongation) compared to dissociated cultures, highlighting the importance of the tissue context in drug response.

5. Significance

PHIROS represents a paradigm shift in ex vivo tissue modeling by bridging the gap between the physiological relevance of organotypic slices and the technical requirements of high-resolution, long-term live imaging.

• Mechanistic Insights: It enables the study of complex, multicellular processes (e.g., organelle transfer, network signaling, tumor invasion) in a native tissue context that is impossible to replicate with dissociated cells or 2D models.
• Personalized Medicine: The platform's ability to use pediatric tissue (mimicking pediatric tumor biology) with short experimental timelines makes it highly suitable for personalized drug screening and mechanistic studies of pediatric brain tumors like medulloblastoma.
• Therapeutic Targets: By revealing dynamic behaviors like B7-H3 polarization and mitochondrial transfer, PHIROS identifies new potential therapeutic targets and mechanisms of therapy resistance (e.g., via tumor microtubes).

In summary, PHIROS provides a robust, versatile, and physiologically relevant platform for interrogating cellular dynamics in intact tissues, overcoming the historical trade-off between tissue complexity and imaging resolution.